Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 2071 AL 2085

Two different axes CALCOCO2-RB1CC1 and OPTN-ATG9A initiate PRKN-mediated mitophagy

Yamano K, Youle RJ.

Autophagy. 2020 Nov;16(11):2105-2107. doi: 10.1080/15548627.2020.1815457. Epub 2020 Sep 7.

Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trial

Domellöf ME, Walton L, Boraxbekk CJ, Bäckström D, Josefsson M, Forsgren L, Stigsdotter Neely A.

BMC Neurol. 2020 Sep 7;20(1):337. doi: 10.1186/s12883-020-01893-z.

Minority Enrollment in Parkinson's Disease Clinical Trials: Meta-Analysis and Systematic Review of Studies Evaluating Treatment of Neuropsychiatric Symptoms

Di Luca DG, Sambursky JA, Margolesky J, Cordeiro JG, Diaz A, Shpiner DS, Moore HP, Singer C, Luca C.

J Parkinsons Dis. 2020;10(4):1709-1716. doi: 10.3233/JPD-202045.

Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson's Disease

Tarolli CG, Andrzejewski K, Zimmerman GA, Bull M, Goldenthal S, Auinger P, O'Brien M, Dorsey ER, Biglan K, Simuni T.

J Parkinsons Dis. 2020;10(4):1779-1786. doi: 10.3233/JPD-202163.

Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial

Tan AH, Lim SY, Mahadeva S, Loke MF, Tan JY, Ang BH, Chin KP, Mohammad Adnan AF, Ong SMC, Ibrahim AI, Zulkifli N, Lee JK, Lim WT, Teo YT, Kok YL, Ng TY, Tan AGS, Zulkifle IM, Ng CK, Ee SS, Arafin S, Mohamad Shukori K, Vadivelu JS, Marras C, Fox SH, Lang AE.

Mov Disord. 2020 Dec;35(12):2250-2260. doi: 10.1002/mds.28248. Epub 2020 Sep 7.

Young-Onset Parkinson's Disease with Impulse Control Disorder Due to Novel Variants of F-Box Only Protein 7

Yoo D, Choi JH, Im JH, Kim MJ, Kim HJ, Park SS, Jeon B.

J Mov Disord. 2020 Sep;13(3):225-228. doi: 10.14802/jmd.20026. Epub 2020 Sep 9.

Morbidity and mortality in orthostatic hypotension

Farrell MC, Shibao CA.

Auton Neurosci. 2020 Dec;229:102717. doi: 10.1016/j.autneu.2020.102717. Epub 2020 Aug 17.

[Insomnia comorbid to Parkinson's disease Part II: Therapeutic approaches]

Lebrun C, Gély-Nargeot MC, Bayard S.

Geriatr Psychol Neuropsychiatr Vieil. 2020 Sep 1;18(3):331-342. doi: 10.1684/pnv.2020.0881.

Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease

Pascale E, Divisato G, Palladino R, Auriemma M, Ngalya EF, Caiazzo M.

Biomolecules. 2020 Sep 3;10(9):1269. doi: 10.3390/biom10091269.

Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease

Acharya S, Salgado-Somoza A, Stefanizzi FM, Lumley AI, Zhang L, Glaab E, May P, Devaux Y.

Int J Mol Sci. 2020 Sep 6;21(18):6513. doi: 10.3390/ijms21186513.

KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease

Fleisher JE, Sennott BJ, Myrick E, Niemet CJ, Lee M, Whitelock CM, Sanghvi M, Liu Y, Ouyang B, Hall DA, Comella CL, Chodosh J.

PLoS One. 2020 Sep 9;15(9):e0237777. doi: 10.1371/journal.pone.0237777. eCollection 2020.

Gray Matter Alterations in Parkinson's Disease With Rapid Eye Movement Sleep Behavior Disorder: A Meta-Analysis of Voxel-Based Morphometry Studies

Yang C, Chang J, Liang X, Bao X, Wang R.

Front Aging Neurosci. 2020 Aug 12;12:213. doi: 10.3389/fnagi.2020.00213. eCollection 2020.

Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function

Oliveira da Silva MI, Liz MA.

Front Cell Dev Biol. 2020 Aug 12;8:787. doi: 10.3389/fcell.2020.00787. eCollection 2020.

Efficacy and Characteristics of the Stimuli of Action Observation Therapy in Subjects With Parkinson's Disease: A Systematic Review

Temporiti F, Adamo P, Cavalli E, Gatti R.

Front Neurol. 2020 Aug 13;11:808. doi: 10.3389/fneur.2020.00808. eCollection 2020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias